Fungal Extracellular Vesicles as a Potential Strategy for Vaccine Development.

Extracellular vesicles (EVs) are released by virtually all live cells. In fungal organisms, the EVs traverse the cell wall and reach the extracellular environment, where they can interact with host cells and potentially impact the disease outcome. Compositional analyses have demonstrated that fungal EVs carry lipids, proteins, polysaccharides, glycans, nucleic acids, and a diversity of small metabolites. Among this variety of compounds, several molecules with immunogenic properties were characterized. It corroborates with their ability to stimulate innate immune cells, induce antibody production and protect insects and mice against fungal infections. In this chapter, we discuss the advantages of using fungal EVs as a new platform for the development of antifungal vaccines.